TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
UNCY

Unicycive Therapeutics Inc

Healthcare · Biotechnology

4.20$ -0.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Unicycive Therapeutics Inc (UNCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 72 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UNCY
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
19 14 52 45 39 32 28 30 51 49 64 72
19 13 52 44 38 31 27 30 50 49 64 71
14 9.7 49 42 32 26 20 22 43 29 37 44
14 9.7 49 42 32 26 20 22 43 41 55 61
16 18 31 13 11 24 17 14 13 19 27 19
15 18 30 13 10 24 17 14 13 19 26 19
0.3 0.3 0.3 0.4 0.5 0.7 0.7 0.5 0.5 0.2 0.7 0.6
1.0 0.8 1.2 1.4 0.5 1.0 1.3 0.7 0.7 0.3 1.0 2.2
3.4 -3.8 22 31 28 7.4 11 16 37 30 38 53
-57 -65 -86 -76 -80 -101 -101 -107 -113 -128 -141 -142
3.3 3.5 3.5 3.8 8.9 7.8 12 12 18 20 24 27

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?